TRAIL gene expressing-stem cell therapy (Medical Research Council)

N/A

Report date: 2025/03/20 09:16:08

Base Information

Drug NameTRAIL gene expressing-stem cell therapy (Medical Research Council)
Drug Alias Namecombined stem cell-gene therapy (Medical Research Council)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionTumor necrosis factor ligand superfamily member 10 modulators
TargetsTumor necrosis factor ligand superfamily member 10
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedical Research Council
China Registration ClassN/A

Develop Information

Active CompaniesMedical Research Council
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A